Connective Tissues of the Subendothelium

Vascular Medicine: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2006, Pages 31-60

  Creager, Mark A ^a   Dzau, Victor J ^b   Loscalzo, Joseph ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869167587     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0284-4.50009-9     Document Type: Chapter

References (147)

1. Fleishmajer R, Olsen B, Kuhn K Structure, molecular biology, and pathology of collagens. Ann NYAcad Sci 1990, 580:1.
2. Prockop DJ, Kivirikko KI Collagens: Molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995, 64:403.
3. Myllyharju J, Kivirikko KI Collagens and collagen-related diseases. Ann Med 2001, 33:7.
4. Plenz GA, Deng MC, Robenek H, et al. Vascular collagens: Spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis 2003, 166:1.
5. Hudson BG, Reeders ST, Tryggvason K Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993, 268:26033.
6. Chernousov MA, Rothblum K, Tyler WA, et al. Schwann cells synthesize type V collagen that contains a novel alpha 4 chain. Molecular cloning, biochemical characterization, and high affinity heparin binding of alpha 4(V) collagen. J Biol Chem 2000, 275:28208.
7. Chung E, Rhodes K, Miller EJ Isolation of three collagenous components of probable basement membrane origin from several tissues. Biochem Biophys Res Commun 1976, 71:1167.
8. Kielty CM, Grant ME The collagen family: Structure, assembly and organization in the extracellular matrix. Connective Tissue and its Heritable Disorders (2nd ed) 2002, 159. Wiley & Sons, New York. P.M. Royce, B. Steimann (Eds.).
9. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277.
10. Sasaki T, Larsson H, Tisi D, et al. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 2000, 301:1179.
11. Ortega N, Werb Z New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci 2002, 115:4201.
12. Madri JA, Dreyer B, Pitlick FA, et al. The collagenous components of the subendothelium: Correlation of structure and function. Lab Invest 1980, 43:303.
13. Borza DB, Bondar O, Ninomiya Y, et al. The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes. J Biol Chem 2001, 276:28532.
14. Grassel S, Timpl R, Tan EM, et al. Biosynthesis and processing of type XVI collagen in human fibroblasts and smooth muscle cells. Eur J Biochem 1996, 242:576.
15. Graf R, Matejevic D, Schuppan D, et al. Molecular anatomy of the perivascular sheath in human placental stem villi: The contractile apparatus and its association to the extracellular matrix. Cell Tissue Res 1997, 290:601.
16. Wang Q, Raghow R Molecular mechanisms of regulation of type collagen biosynthesis. Proc Indian Acad Sci 1999, 111:185.
17. Bornstein P Regulation of expression of the alpha 1 (I) collagen gene: A critical appraisal of the role of the first intron. Matrix Biol 1996, 15:3.
18. Birk DE, Trelstad RL Fibroblasts create compartments in the extracellular space where collagen polymerizes into fibrils and fibrils associate into bundles. Ann NYAcad Sci 1985, 460:258.
19. Bornstein P, Horlein D, McPherson J Regulation of collagen synthesis, myelofibrosis and the biology of connective tissue. Prog Clin Biol Res 1984, 154:61.
20. Aycock RS, Raghow R, Stricklin GP, et al. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem 1986, 261:14355.
21. Tanzer M Cross-linking (of collagen). Biochemistry of Collagen 1976, 192. Plenum, New York. G.N. Ramachandran, A.H. Reddi (Eds.).
22. Fujimoto D, Moriguchi T, Ishida T, et al. The structure of pyridino-line:A collagen crosslink. Biochem Biophys Res Commun 1978, 84:52.
23. Bernstein PH, Mechanic GL A natural histidine-based imminium cross-link in collagen and its location. J Biol Chem 1980, 255:10414.
24. Nagase H, Woessner JF Matrix metalloproteinases. J Biol Chem 1999, 274:21491.
25. Sternlicht MD, Werb Z How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463.
26. Murphy G, Nguyen Q, Cockett MI, et al. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 1994, 269:6632.
27. Shipley JM, Doyle GA, Fliszar CJ, et al. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases: Role of the fibronectin type II-like repeats. J Biol Chem 1996, 271:4335.
28. Woessner JF, Nagase H Matrix Metalloproteinases and TIMPs 2002, 238. Oxford University Press, New York.
29. Smith MR, Kung H, Durum SK, et al. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997, 9:770.
30. Ahonen M, Baker AH, Kahari VM Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998, 58:2310.
31. Ruoslahti E Specialization of tumour vasculature. Nat Rev Cancer 2002, 2:83.
32. Silletti S, Kessler T, Goldberg J, et al. Disruption of matrix metallo-proteinase 2 binding to integrin alpha v beta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci U S A 2001, 98:119.
33. Timpl R, Oberbaumer I, von der Mark H, et al. Structure and biology of the globular domain of basement membrane type IV collagen. Ann NYAcad Sci 1985, 460:58.
34. Timpl R, Brown JC Supramolecular assembly of basement membranes. Bioessays 1996, 18:123.
35. Fauvel-Lafeve F Microfibrils from the arterial subendothelium. Int Rev Cytol 1999, 188:1.
36. Wu XX, Gordon RE, Glanville RW, et al. Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium. Am J Pathol 1996, 149:283.
37. Kuo HJ, Keene DR, Glanville RW The macromolecular structure of type-VI collagen: Formation and stability of filaments. Eur J Biochem 1995, 232:364.
38. Dingemans KP, Teeling P, Lagendijk JH, et al. Extracellular matrix of the human aortic media: An ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 2000, 258:1.
39. Ferreras M, Felbor U, Lenhard T, et al. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000, 486:247.
40. Mecham RP, Davis EC Elastic fiber structure and assembly. Extracellular Matrix Assembly and Structure 1994, 281. Academic Press, New York. P.D. Yurchenco, D.E. Birk, R.P. Mecham (Eds.).
41. Brooke BS, Bayes-Genis A, Li DY New insights into elastin and vascular disease. Trends Cardiovasc Med 2003, 13:176.
42. Faury G Function-structure relationship of elastic arteries in evolution: From microfibrils to elastin and elastic fibres. Pathol Biol (Paris) 2001, 49:310.
43. Trask BC, Trask TM, Broekelmann T, et al. The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol Biol Cell 2000, 11:1499.
44. Trask TM, Trask BC, Ritty TM, et al. Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly. J Biol Chem 2000, 275:24400.
45. Siegel RC Lysyl oxidase. Int Rev Connect Tissue Res 1979, 8:73.
46. Partridge SM, Elsden DF, Thomas J, et al. Biosynthesis of the desmosine and isodesmosine cross-bridges in elastin. Biochem J 1964, 93:30C.
47. Miller EJ, Martin GR, Piez KA The utilization of lysine in the biosynthesis of elastin crosslinks. Biochem Biophys Res Commun 1964, 17:248.
48. Bashir MM, Indik Z, Yeh H, et al. Characterization of the complete human elastin gene: Delineation of unusual features in the 5'-flanking region. J Biol Chem 1989, 264:8887.
49. Kozel BA, Wachi H, Davis EC, et al. Domains in tropoelastin that mediate elastin deposition in vitro and in vivo. J Biol Chem 2003, 278:18491.
50. Foster JA, Rubin L, Kagan HM, et al. Isolation and characterization of cross-linked peptides from elastin. J Biol Chem 1974, 249:6191.
51. Indik Z, Yeh H, Ornstein-Goldstein N, et al. Structure of the elastin gene and alternative splicing of elastin mRNA: Implications for human disease. Am J Med Genet 1989, 34:81.
52. Galis ZS, Khatri JJ Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002, 90:251.
53. Brooke BS, Bays-Gerris A, Li DY New insights into elastin and vascular disease. Trends Cardiovasc Med 2003, 13:176.
54. Li DY, Brooke B, Davis EC, et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393:276.
55. Li DY, Faury G, Taylor DG, et al. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest 1998, 102:1783.
56. Urban Z, Riazi S, Seidl TL, et al. Connection between elastin hap-loinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am J Hum Genet 2002, 71:30.
57. Karnik SK, Brooke BS, Bayes-Genis A, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003, 130:411.
58. Raines EW The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationships to vascular disease. Int J Exp Pathol 2000, 81:173.
59. Waugh JM, Li-Hawkins J, Yuksel E, et al. Therapeutic elastase inhibition by alpha-1-antitrypsin gene transfer limits neointima formation in normal rabbits. J Vasc Interv Radiol 2001, 12:1203.
60. Zaidi SH, You XM, Ciura S, et al. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 2002, 105:516.
61. Hynes RO Fibronectins 1990, 546. Springer, New York.
62. Magnusson MK, Mosher DF Fibronectin: Structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998, 18:1363.
63. Yamada KM, Danen EH Integrin signaling. Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Disease 2000, 1. Humana Press, Totowa, NJ. J.S. Gutkind (Ed.).
64. Hynes RO Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11.
65. Yamada KM Fibronectin peptides in cell migration and wound repair. J Clin Invest 2000, 105:1507.
66. Danen EH, Yamada KM Fibronectin, integrins, and growth control. J Cell Physiol 2001, 189:1.
67. DeSimone DW Adhesion and matrix in vertebrate development. Curr Opin Cell Biol 1994, 6:747.
68. Ginsberg MH, Loftus JC, Plow EF Cytoadhesins, integrins, and platelets. Thromb Haemost 1988, 59:1.
69. Mosher D Fibronectin. Fibronectins: Biology of extracellular matrix 1989, 530. Academic Press, San Diego. D.F. Mosher (Ed.).
70. Bisno AL, Brito MO, Collins CM Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003, 3:191.
71. Schwarz-Linek U, Plevin MJ, Pickford AR, et al. Binding of a peptide from a Streptococcus dysgalactiae MSCRAMM to the N-terminal F1 module pair of human fibronectin involves both modules. FEBS Lett 2001, 497:137.
72. Klebe RJ Isolation of a collagen-dependent cell attachment factor. Nature 1974, 250:248.
73. Kleinman HK, Klebe RJ, Martin GR Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 1981, 88:473.
74. Engvall E, Ruoslahti E, Miller EJ Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 1978, 147:1584.
75. Wierzbicka-Patynowski I, Schwarzbauer JE The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 116:3269.
76. Raghow R The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994, 8:823.
77. Aumailley M, Pesch M, Tunggal L, et al. Altered synthesis of laminin 1 and absence of basement membrane component deposition in (beta)1 integrin-deficient embryoid bodies. J Cell Sci 113 Pt 2000, 2:259.
78. Aumailley M, Smyth N The role of laminins in basement membrane function. J Anat 1998, 193(Pt 1):1.
79. Colognato H, Yurchenco PD Form and function: The laminin family of heterotrimers. Dev Dyn 2000, 218:213.
80. Beck K, Dixon TW, Engel J, et al. Ionic interactions in the coiled-coil domain of laminin determine the specificity of chain assembly. J Mol Biol 1993, 231:311.
81. Engbring JA, Kleinman HK The basement membrane matrix in malignancy. J Pathol 2003, 200:465.
82. Kleinman HK, Koblinski J, Lee S, et al. Role of basement membrane in tumor growth and metastasis. Surg Oncol Clin N Am 2001, 10:329.
83. Powell SK, Kleinman HK Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 1997, 29:401.
84. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992, 8:365.
85. Iozzo RV Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 1998, 67:609.
86. Iozzo RV The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997, 32:141.
87. Kjellen L, Lindahl U Proteoglycans: Structures and interactions. Annu Rev Biochem 1991, 60:443.
88. Roughley PJ, Lee ER Cartilage proteoglycans: Structure and potential functions. Microsc Res Tech 1994, 28:385.
89. Drickamer K A conserved disulphide bond in sialyltransferases. Glycobiology 1993, 3:2.
90. Li H, Schwartz NB, Vertel BM cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chon-drodystrophy, nanomelia. J Biol Chem 1993, 268:23504.
91. Watanabe H, Kimata K, Line S, et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat Genet 1994, 7:154.
92. Yamaguchi Y Lecticans: Organizers of the brain extracellular matrix. Cell Mol Life Sci 2000, 57:276.
93. Seidenbecher CI, Richter K, Rauch U, et al. Brevican: A chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms. J Biol Chem 1995, 270:27206.
94. Danielson KG, Baribault H, Holmes DF, et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729.
95. Vogel KG, Paulsson M, Heinegard D Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984, 223:587.
96. Hedbom E, Heinegard D Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993, 268:27307.
97. Nurminskaya MV, Birk DE Differential expression of fibromodulin mRNA associated with tendon fibril growth: Isolation and characterization of a chicken fibromodulin cDNA. Biochem J 1996, 317(Pt 3):785.
98. Birk DE, Nurminskaya MV, Zycband EI Collagen fibrillogenesis in situ: Fibril segments undergo post-depositional modifications resulting in linear and lateral growth during matrix development. Dev Dyn 1995, 202:229.
99. Lindahl U, Kusche-Gullberg M, Kjellen L Regulated diversity of heparan sulfate. J Biol Chem 1998, 273:24979.
100. Ruoslahti E Structure and biology of proteoglycans. Annu Rev Cell Biol 1988, 4:229.
101. Fellini SA, Kimura JH, Hascall VC Polydispersity of proteoglycans synthesized by chondrocytes from the Swarm rat chondrosar-coma. J Biol Chem 1981, 256:7883.
102. Schiller S, Mathews MB, Cifonelli JA, et al. The metabolism of mucopolysaccharides in animals. III. Further studies on skin utilizing C14-glucose, C14-acetate, and S35-sodium sulfate. J Biol Chem 1956, 218:139.
103. Truppe W, Kresse H Uptake of proteoglycans and sulfated gly-cosaminoglycans by cultured skin fibroblasts. Eur J Biochem 1978, 85:351.
104. Fluharty AL The mucopolysaccharidoses: A synergism between clinical and basic investigation. J Invest Dermatol 79 Suppl 1982, 1:38s.
105. van der Flier A, Sonnenberg A Function and interactions of integrins. Cell Tissue Res 2001, 305:285.
106. Hemler ME Integrins. Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins 1999, 196. Oxford University Press. T. Kreis, R. Vale (Eds.).
107. Hynes RO Targeted mutations in cell adhesion genes: What have we learned from them?. Dev Biol 1996, 180:402.
108. Hynes RO, Zhao Q The evolution of cell adhesion. J Cell Biol 2000, 150:F89.
109. Hynes RO A reevaluation of integrins as regulators of angiogene-sis. Nat Med 2002, 8:918.
110. Hynes RO Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110:673.
111. Miranti CK, Brugge JS Sensing the environment: A historical perspective on integrin signal transduction. Nat Cell Biol 2002, 4:E83.
112. Schwartz MA, Ginsberg MH Networks and crosstalk: Integrin signaling spreads. Nat Cell Biol 2002, 4:E65.
113. Schaeffer HJ, Weber MJ Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19:2435.
114. Hanks SK, Calalb MB, Harper MC, et al. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A 1992, 89:8487.
115. Kanner SB, Reynolds AB, Parsons JT Immunoaffinity purification of tyrosine-phosphorylated cellular proteins. J Immunol Methods 1989, 120:115.
116. Shichiri M, Hirata Y Antiangiogenesis signals by endostatin. FASEB J 2001, 15:1044.
117. Giancotti FG, Ruoslahti E Integrin signaling. Science 1999, 285:1028.
118. Livant DL, Brabec RK, Kurachi K, et al. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest 2000, 105:1537.
119. Livant DL, Brabec RK, Pienta KJ, et al. Anti-invasive, antitumori-genic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res 2000, 60:309.
120. Bosman FT, Stamenkovic I Functional structure and composition of the extracellular matrix. J Pathol 2003, 200:423.
121. Lander AD, Selleck SB The elusive functions of proteoglycans: In vivo veritas. J Cell Biol 2000, 148:227.
122. Skandalis SS, Theocharis AD, Papageorgakopoulou N, et al. Glycosaminoglycans in early chick embryo. Int J Dev Biol 2003, 47:311.
123. Rapraeger AC, Krufka A, Olwin BB Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705.
124. Yayon A, Klagsbrun M, Esko JD, et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64:841.
125. Culley FJ, Fadlon EJ, Kirchem A, et al. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur J Immunol 2003, 33:1302.
126. Penc SF, Pomahac B, Eriksson E, et al. Dermatan sulfate activates nuclear factor-kappa b and induces endothelial and circulating intercellular adhesion molecule-1. J Clin Invest 1999, 103:1329.
127. Carrell RW, Huntington JA, Mushunje A, et al. The conformational basis of thrombosis. Thromb Haemost 2001, 86:14.
128. Casu B Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate. Semin Thromb Hemost 1991, 17:9.
129. Furie B, Furie BC Molecular and cellular biology of blood coagulation. N Engl J Med 1992, 326:800.
130. Warkentin TE, Greinacher A Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003, 76:638.
131. Cheng CF, Oosta GM, Bensadoun A, et al. Binding of lipoprotein lipase to endothelial cells in culture. J Biol Chem 1981, 256:12893.
132. Shimada K, Gill PJ, Silbert JE, et al. Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J Clin Invest 1981, 68:995.
133. Nilsson-Ehle P, Garfinkel AS, Schotz MC Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem 1980, 49:667.
134. Madri JA, Stenn KS Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol 1982, 106:180.
135. Nieswandt B, Watson SP Platelet-collagen interaction: Is GPVI the central receptor?. Blood 2003, 102:449.
136. Morton LF, Hargreaves PG, Farndale RW, et al. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like pep-tides: Collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J 1995, 306:337.
137. Zheng XF, Podell S, Sefton BM, et al. The sequence of chicken c-yes and p61c-yes. Oncogene 1989, 4:99.
138. Berlanga O, Tulasne D, Bori T, et al. The Fc receptor gamma-chain is necessary and sufficient to initiate signaling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin. EurJ Biochem 2002, 269:2951.
139. Suzuki-Inoue K, Tulasne D, Shen Y, et al. Association of Fyn and Lyn with the praline-rich domain of glycoprotein VI regulates intra-cellular signaling. J Biol Chem 2002, 277:21561.
140. Andrews DA, Yang L, Low PS Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. Blood 2002, 100:3392.
141. Chiang TM, Cole F, Woo-Rasberry V Cloning, characterization, and functional studies of a 47-kDa platelet receptor for type III collagen. J Biol Chem 2002, 277:34896.
142. Chiang TM, Rinaldy A, Kang AH Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen. J Clin Invest 1997, 100:514.
143. Monnet E, Depraetere H, Legrand C, et al. A monoclonal antibody to platelet type III collagen-binding protein (TIIICBP) binds to blood and vascular cells, and inhibits platelet vessel-wall interactions. Thromb Haemost 2001, 86:694.
144. Monnet E, Fauvel-Lafeve F A new platelet receptor specific to type III collagen. Type III collagen-binding protein. J Biol Chem 2000, 275:10912.
145. Moog S, Mangin P, Lenain N, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001, 98:1038.
146. Ni H, Ramakrishnan V, Ruggeri ZM, et al. Increased thrombogenesis and embolus formation in mice lacking glycoprotein. V Blood 2001, 98:368.
147. Arteaga-Solis E, Gayraud B, Ramirez F Elastic and collagenous networks in vascular diseases. Cell Struct Funct 2000, 25:69.